Norwegian life-sciences group Lifecare AS plans to begin trading today on the Merkur Market under the ticker symbol ‘LIFE-ME’. The company is developing an implantable glucose sensor designed for people living with diabetes. Get the full story at our sister site, Drug Delivery Business News.